Invention Grant
US08815901B2 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
有权
喹啉羧酰胺衍生物作为蛋白酪氨酸激酶抑制剂
- Patent Title: Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
- Patent Title (中): 喹啉羧酰胺衍生物作为蛋白酪氨酸激酶抑制剂
-
Application No.: US13962542Application Date: 2013-08-08
-
Publication No.: US08815901B2Publication Date: 2014-08-26
- Inventor: Pascal Furet , Diana Graus Porta , Vito Guagnano
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Laura Madden
- Priority: EP08156846 20080523
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D215/16
Abstract:
The invention relates to compounds of formula (I) wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, N-oxide thereof; processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases.
Public/Granted literature
- US20130324519A1 QUINOXALINE CARBOXAMIDE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS Public/Granted day:2013-12-05
Information query
